Cal-Maine Foods Inc. (CALM) Jumps 5.15% on January 18

Equities Staff  |

Cal-Maine Foods Inc. (CALM) was among the biggest gainers on the Russell 2000 for Monday January 18 as the stock popped 5.15% to $49.39, representing a gain of $2.42 per share. Some 2.01 million shares traded hands on 14,160 trades, compared with an average daily volume of 1.03 million shares out of a total float of 48.49 million. The stock opened at $46.38 and traded with an intraday range of $52.00 to $46.38.

After today's gains, Cal-Maine Foods Inc. reached a market cap of $2.4 billion. Cal-Maine Foods Inc. has had a trading range between $63.25 and $34.03 over the last year, and it had a 50-day SMA of $50.80 and a 200-day SMA of $51.27.

The stock has a P/E Ratio of 6.9.

Cal-Maine Foods Inc is a producer and marketer of shell eggs in the United States. The Company's main business is the production, grading, packaging, marketing and distribution of shell eggs.

Cal-Maine Foods Inc. is based out of Jackson, MS and has some 2,872 employees. Its CEO is Adolphus B. Baker.

For a complete fundamental analysis analysis of Cal-Maine Foods Inc., check out’s Stock Valuation Analysis report for CALM. To see the latest independent stock recommendations from’s analysts, visit our Research section.

The Russell 2000 is one of the leading indices tracking small-cap companies in the United States. It's maintained by Russell Investments, an industry leader in creating and maintaining indices, and consists of the smallest 2000 stocks from the broader Russell 3000 index.

Russell's indices differ from traditional indices like the Dow Jones Industrial Average (DJIA) or S&P 500, whose members are selected by committee, because they base membership entirely on an objective, rules based methodology. The 3,000 largest companies by market cap make up the Russell 3000, with the 2,000 smaller companies making up the Russell 2000. It's a simple approach that gives a broad, unbiased look at the small-cap market as a whole.

For more news on the financial markets, go to Also, learn more about our independent proprietary equity research reports and our robust do-it-yourself Stock Valuation Analysis reports in our Research section.

All data provided by QuoteMedia and was accurate as of 4:30PM ET.

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to:



Symbol Last Price Change % Change










What Is Petrolithium?

MGX Minerals explains the advantages of petrolithium and how they are helping to solve future problems today.

Emerging Growth

IMV Inc.

Immunovaccine Inc is clinical stage biopharmaceutical company. The Company develops products based on its proprietary vaccine enhancement platform in T cell activating therapies for cancer.